Literature DB >> 23010981

The accuracy and reproducibility of SPECT target volumes and activities estimated using an iterative adaptive thresholding technique.

Joshua Grimes1, Anna Celler, Sergey Shcherbinin, Hanna Piwowarska-Bilska, Bozena Birkenfeld.   

Abstract

OBJECTIVE: Our aim was to design a practical and reproducible image segmentation method for calculations of total absorbed doses in organs and tumours for internally delivered radioisotopes. We have built upon our previously proposed use of two separate thresholds and employed an iterative technique for semiautomatic selection of background regions for segmenting an object of interest using thresholds that depend on the source-to-background ratio of activity concentrations.
METHODS: The parameters of curves relating volume and activity thresholds to source-to-background ratio were established using phantoms with 20 different inserts. The accuracy of our technique was validated using a second phantom experiment, whereas the reproducibility of volume, activity and dose estimates of organs and tumours was investigated using 13 patient studies. The accuracy and reproducibility of segmentations achieved were assessed using images reconstructed with three different methods that ranged from a standard clinical reconstruction to an advanced quantitative reconstruction approach.
RESULTS: In the validation phantom experiment, bottle volumes and activities measured using iterative adaptive thresholding agreed on average with the true values to within 4%, regardless of the reconstruction method used. In the patient studies, volumes and activities estimated from the single-photon emission computed tomography images reconstructed with clinical software agreed with the volumes and activities estimated using the advanced reconstruction approach to within 6%, whereas the corresponding doses agreed to within 4%.
CONCLUSION: The proposed iterative adaptive thresholding technique can accurately determine object volume and activity, which allows standard clinical reconstructions to generate absorbed dose estimates that are similar to those values obtained using more advanced reconstruction methods.

Entities:  

Mesh:

Year:  2012        PMID: 23010981     DOI: 10.1097/MNM.0b013e3283598395

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications.

Authors:  Yuni K Dewaraja; Michael Ljungberg; Alan J Green; Pat B Zanzonico; Eric C Frey; Wesley E Bolch; A Bertrand Brill; Mark Dunphy; Darrell R Fisher; Roger W Howell; Ruby F Meredith; George Sgouros; Barry W Wessels
Journal:  J Nucl Med       Date:  2013-10-15       Impact factor: 10.057

2.  Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children.

Authors:  Xinchi Hou; Bozena Birkenfeld; Hanna Piwowarska-Bilska; Anna Celler
Journal:  EJNMMI Phys       Date:  2017-10-13

3.  SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy.

Authors:  Johan Gustafsson; Anna Sundlöv; Katarina Sjögreen Gleisner
Journal:  EJNMMI Res       Date:  2017-02-23       Impact factor: 3.138

4.  Accuracy of 177Lu activity quantification in SPECT imaging: a phantom study.

Authors:  Carlos F Uribe; Pedro L Esquinas; Jesse Tanguay; Marjorie Gonzalez; Emilie Gaudin; Jean-Mathieu Beauregard; Anna Celler
Journal:  EJNMMI Phys       Date:  2017-01-07

5.  EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.

Authors:  Katarina Sjögreen Gleisner; Nicolas Chouin; Pablo Minguez Gabina; Francesco Cicone; Silvano Gnesin; Caroline Stokke; Mark Konijnenberg; Marta Cremonesi; Frederik A Verburg; Peter Bernhardt; Uta Eberlein; Jonathan Gear
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-14       Impact factor: 10.057

6.  Radiolabeled liposome imaging determines an indication for liposomal anticancer agent in ovarian cancer mouse xenograft models.

Authors:  Ken Ito; Shusei Hamamichi; Makoto Asano; Yusaku Hori; Junji Matsui; Masao Iwata; Yasuhiro Funahashi; Izumi O Umeda; Hirofumi Fujii
Journal:  Cancer Sci       Date:  2015-11-30       Impact factor: 6.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.